Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CTKB NASDAQ:FEIM NYSE:INTT NASDAQ:PRE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCTKBCytek Biosciences$4.46-2.2%$4.24$3.28▼$6.18$575.98M1.17833,855 shs597,204 shsFEIMFrequency Electronics$72.46-1.1%$67.01$24.72▼$80.51$715.19M0.71321,397 shs346,103 shsINTTinTEST$13.78-6.3%$16.41$6.63▼$20.00$173.15M1.47221,560 shs124,653 shsPREPrenetics Global$18.74-3.5%$19.03$7.18▼$23.63$316.22M0.26249,307 shs149,200 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCTKBCytek Biosciences0.00%-3.46%-0.22%+1.36%+32.34%FEIMFrequency Electronics0.00%+9.95%+15.77%+40.59%+180.64%INTTinTEST0.00%+2.53%-22.93%-24.95%+84.72%PREPrenetics Global0.00%+2.46%-5.11%+2.24%+117.15%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCTKBCytek Biosciences$4.46-2.2%$4.24$3.28▼$6.18$575.98M1.17833,855 shs597,204 shsFEIMFrequency Electronics$72.46-1.1%$67.01$24.72▼$80.51$715.19M0.71321,397 shs346,103 shsINTTinTEST$13.78-6.3%$16.41$6.63▼$20.00$173.15M1.47221,560 shs124,653 shsPREPrenetics Global$18.74-3.5%$19.03$7.18▼$23.63$316.22M0.26249,307 shs149,200 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCTKBCytek Biosciences0.00%-3.46%-0.22%+1.36%+32.34%FEIMFrequency Electronics0.00%+9.95%+15.77%+40.59%+180.64%INTTinTEST0.00%+2.53%-22.93%-24.95%+84.72%PREPrenetics Global0.00%+2.46%-5.11%+2.24%+117.15%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCTKBCytek Biosciences 2.33Hold$5.6927.52% UpsideFEIMFrequency Electronics 3.00Buy$43.67-39.74% DownsideINTTinTEST 2.50Moderate Buy$19.0037.88% UpsidePREPrenetics Global 2.60Moderate Buy$34.2582.76% UpsideCurrent Analyst Ratings BreakdownLatest INTT, FEIM, CTKB, and PRE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/20/2026FEIMFrequency Electronics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C+) ➝ Hold (C)7/17/2026PREPrenetics Global Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)7/15/2026PREPrenetics Global BenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$30.00 ➝ $40.006/24/2026CTKBCytek Biosciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)6/16/2026PREPrenetics Global BenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$30.006/15/2026FEIMFrequency Electronics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)6/3/2026INTTinTEST Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold5/13/2026CTKBCytek Biosciences StephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$5.50 ➝ $4.755/12/2026CTKBCytek Biosciences Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$6.00 ➝ $5.505/5/2026FEIMFrequency Electronics Freedom CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy5/5/2026INTTinTEST Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy(Data available from 7/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCTKBCytek Biosciences$201.49M2.86N/AN/A$2.67 per share1.67FEIMFrequency Electronics$63.23M11.31$0.39 per share185.57$5.73 per share12.65INTTinTEST$121.07M1.43$2.40 per share5.75$7.92 per share1.74PREPrenetics Global$92.39M3.42N/AN/A$9.27 per share2.02Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCTKBCytek Biosciences-$66.54M-$0.57N/A223.00N/A-36.25%-10.07%-7.56%8/5/2026 (Estimated)FEIMFrequency Electronics-$900K-$0.09N/AN/AN/A-1.43%-1.56%-0.98%9/10/2026 (Estimated)INTTinTEST$9.34M$0.0459.9234.45N/A2.33%5.31%3.42%N/APREPrenetics Global-$37.71M-$4.58N/AN/AN/A-62.45%-20.33%-15.42%9/11/2026 (Estimated)Latest INTT, FEIM, CTKB, and PRE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2026Q2 2026CTKBCytek Biosciences-$0.02N/AN/AN/A$47.31 millionN/A7/15/2026Q4 2026FEIMFrequency Electronics$0.2650-$0.50-$0.7650-$0.50$18.58 million$15.40 million6/10/2026Q1 2026 PreliminaryPREPrenetics Global-$0.49-$0.56-$0.07-$1.36$36.00 million$35.95 million5/7/2026Q1 2026CTKBCytek Biosciences-$0.08-$0.15-$0.07-$0.15$44.23 million$44.14 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCTKBCytek BiosciencesN/AN/AN/AN/AN/AFEIMFrequency ElectronicsN/AN/AN/AN/AN/AINTTinTESTN/AN/AN/AN/AN/APREPrenetics GlobalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCTKBCytek BiosciencesN/A4.694.07FEIMFrequency ElectronicsN/A2.291.21INTTinTEST0.082.261.38PREPrenetics GlobalN/A5.154.60Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCTKBCytek Biosciences69.46%FEIMFrequency Electronics58.60%INTTinTEST63.18%PREPrenetics Global25.01%Insider OwnershipCompanyInsider OwnershipCTKBCytek Biosciences10.36%FEIMFrequency Electronics28.00%INTTinTEST5.20%PREPrenetics GlobalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCTKBCytek Biosciences500129.14 million115.76 millionOptionableFEIMFrequency Electronics2009.87 million7.11 millionNot OptionableINTTinTEST32012.57 million11.69 millionOptionablePREPrenetics Global116.87 millionN/ANot OptionableINTT, FEIM, CTKB, and PRE HeadlinesRecent News About These CompaniesWall Street Zen Downgrades Prenetics Global (NASDAQ:PRE) to SellJuly 25 at 1:30 AM | americanbankingnews.comPrenetics Global (NASDAQ:PRE) Lowered to "Sell" Rating by Wall Street ZenJuly 25 at 1:29 AM | marketbeat.comPrenetics Global: Path To Profitability On Course With Financing DealJuly 24 at 12:48 PM | seekingalpha.comTESLA AND ALPHABET SHARES SLUMP IN PRE-MARKET TRADINGJuly 23 at 7:00 AM | youtube.comYSidoti Estimates Prenetics Global's Q3 Earnings (NASDAQ:PRE)July 19, 2026 | americanbankingnews.comPrenetics’ IM8 Secures $1 Billion Non-Dilutive Financing as Revenue Outlook RisesJuly 17, 2026 | theglobeandmail.comPRE Continues to Exceed Expectations and Receive Preferential FinancingJuly 17, 2026 | msn.comPrenetics CEO on securing $1 billion funding to fuel subsidiary IM8's growthJuly 17, 2026 | msn.comQ3 Earnings Forecast for Prenetics Global Issued By SidotiJuly 17, 2026 | marketbeat.comPrenetics Global Limited (NASDAQ:PRE) Given Consensus Recommendation of "Moderate Buy" by AnalystsJuly 17, 2026 | americanbankingnews.comQ1 Earnings Estimate for Prenetics Global Issued By SidotiJuly 16, 2026 | marketbeat.comPrenetics Global (NASDAQ:PRE) Given New $40.00 Price Target at BenchmarkJuly 16, 2026 | americanbankingnews.comPrenetics Global (NASDAQ:PRE) Price Target Raised to $40.00July 15, 2026 | marketbeat.comPrenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)July 14, 2026 | markets.businessinsider.comPrenetics Raises $1 Billion Growth Financing from General Catalyst for IM8 and Lifts 2026 Revenue Guidance to $210 Million-$220 MillionJuly 14, 2026 | quiverquant.comQPrenetics' IM8 Secures $1 Billion Growth Financing from General Catalyst's Customer Value Fund (CVF)July 14, 2026 | globenewswire.comPrenetics Global Limited (NASDAQ:PRE) Given Average Rating of "Moderate Buy" by BrokeragesJuly 12, 2026 | marketbeat.comPrenetics Global Limited (PRE) Receives Bullish Coverage as IM8 Targets Supplement Market GrowthJune 25, 2026 | insidermonkey.comPrenetics Global Limited (PRE) Receives Bullish Coverage as IM8 Targets Supplement Market GrowthJune 25, 2026 | finance.yahoo.comCEO chat with Danny Yeung, co-founder and CEO of Prenetics GlobalJune 23, 2026 | msn.comPrenetics Posts Record 2025 Results as IM8 Hits $120 Million ARR and Drives Strategic RefocusJune 15, 2026 | theglobeandmail.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSK Hynix’s Nasdaq Listing Could Reset the AI Memory TradeBy Thomas Hughes | July 7, 20265 Tech Stocks to Buy on the July PullbackBy Thomas Hughes | June 29, 2026Rocket Lab’s Stock Drop Comes With a Bullish TwistBy Ryan Hasson | July 10, 2026Delta Air Lines Lives Up to Its Claims: Shares Can Keep ClimbingBy Thomas Hughes | July 12, 20263 Picks-and-Shovels Stocks Powering the Humanoid Robotics BuildoutBy Ryan Hasson | July 17, 2026INTT, FEIM, CTKB, and PRE Company DescriptionsCytek Biosciences NASDAQ:CTKB$4.46 -0.10 (-2.19%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$4.49 +0.03 (+0.67%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.Frequency Electronics NASDAQ:FEIM$72.46 -0.78 (-1.06%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$71.00 -1.46 (-2.01%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Frequency Electronics, Inc., together with its subsidiaries, engages in designing, development, and manufacturing of precision time and frequency control products and components for microwave integrated circuit applications. It operates through two segments, FEI-NY and FEI-Zyfer. The FEI-NY segment offers precision time and frequency control products for communication satellites, terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military; and provides design and technical support for satellite business. FEI-Zyfer segment offers global positioning system technologies to systems and subsystems for secure communications, both government and commercial, and other locator applications; and engages in sale and support of wireline telecommunications products, including US5G. It markets its products directly and through independent sales representative organizations located in the United States, Europe, and Asia. Frequency Electronics, Inc. was founded in 1961 and is headquartered in Mitchel Field, New York.inTEST NYSE:INTT$13.78 -0.92 (-6.26%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$14.20 +0.42 (+3.05%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies. The Electronic Test segment offers in2, Cobal, and LS series manipulators that hold various test heads and enable an operator to reposition a test head for alternate use with various probers or handlers on a test floor; and docking hardware products, which protect the interface contacts and ensure proper repeatable and precise alignment between the test head's interface board and the prober's probing assembly. This segment also provides tester interfaces that offer electrical connections between the tester and the wafer prober or IC handler; scorpion flying probe test systems that designs and manufactures robotics-based electronic test equipment; and BRiZ automated test and programming services. Its products are used in production testing of wafers and specialized packaged ICs in back-end testing by semiconductor manufacturers. The Environmental Technologies segment provides ThermoStream products that are used in the semi market as a stand-alone temperature management tool, or in various electronic test applications; thermal chambers; thermal platforms; Thermonics temperature conditioning products that offer tempered gas or fluid; and ultra-cold storage solutions, including biomedical freezers, refrigerators, and mobile storage solutions. The Process Technologies segment offers EKOHEAT and EASYHEAT induction heating systems; and digital streaming and image capturing solutions. The company markets and sells its products to semiconductor manufacturers, third-party foundries, test and assembly providers, and original equipment manufacturers. inTEST Corporation was incorporated in 1981 and is headquartered in Mount Laurel, New Jersey.Prenetics Global NASDAQ:PRE$18.74 -0.68 (-3.50%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$19.14 +0.40 (+2.13%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/20- 07/24 Telecom Earnings Reveal a Sector That Finally Looks Healthier AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade? Broadcom May Be the Biggest Winner From Alphabet's Earnings CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Defense Earnings Show Readiness Now and Modernization Ahead Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
